Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Cloxiquine
Cat. No.:
OB0225LY-0255
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Cloxiquine is an antimicrobial compound belonging to the class of aminoquinolines.
Synonym:
5-Chloro-8-quinolinol; Dermofongin; 130-16-5; 5-Chloroquinolin-8-ol; Cloxiquine; 8-Quinolinol, 5-chloro-; 5-Chlorooxine; 8-Hydroxy-5-chloroquinoline
CAS No.:
130-16-5
Compound CID:
2817
Formula:
C9H6ClNO
Formula Weight:
179.6
Specification
Relative Density:
1.412 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Cloxiquine plays an important role in the screening of novel antimicrobial drugs.
Library Information
Targets:
PPAR family
Pathways:
Microbiology/Virology; Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-4
Plate Location:
b11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 306.24 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
33 mg/mL; 183.7 mM
